HOME >> MEDICINE >> NEWS
UCSF breast cancer expert collaborates with Dalai Lama's doctor in Tibetan medicine study: Women needed to participate in trial

Faced with advanced breast cancer, hundreds of women from around the world have sought treatment from Yeshi Dhonden, one of the foremost living authorities on Tibetan medicine who was the Dalai Lama's personal physician for two decades.

Now, in an unprecedented clinical trial, Dhonden and breast cancer experts at the University of California, San Francisco are putting traditional Tibetan medicine to the test as the sole therapy for advanced breast cancer.

"This will be a preliminary study that will look for changes in the size of women's tumors," said Debu Tripathy, MD, director of clinical research at the UC San Francisco Carol Franc Buck Breast Care Center. "The investigational therapy will be individualized to a certain extent, with Dr. Dhonden choosing one of seven Formula for each woman based on his diagnosis and assessment."

UCSF is currently recruiting women for the Tibetan medicine trial, which is approved by the UCSF institutional review board and Food and Drug Administration (FDA). The state of California's Breast Cancer Research Program (BCRP) issued Tripathy a $50,000 grant to develop the study.

To date, no trials have been conducted on a sufficient scale and with the use of rigorous scientific methodologies to fully assess Tibetan medicine and diagnosis. Although Dhonden has treated an estimated 3,000 women with breast cancer during the past 20 years, the responses and clinical benefits are unknown because formal record keeping is not standard in Tibetan medicine.

Dhonden, who is based in Dharamsala, India, visits San Francisco once every four to six months to chart the progress of the women in the one-year trial. Study participants are prohibited from receiving any other treatments while enrolled in the trial, including both conventional and unconventional therapies. All patients will be regularly monitored with standard Western techniques including physical examinations, tomography scans and blood and liver function tests. <
'"/>

Contact: Abby Sinnott
asinnott@pubaff.ucsf.edu
415-885-7277
University of California - San Francisco
7-Oct-1999


Page: 1 2

Related medicine news :

1. International breast cancer prevention study launches in the United States and Canada
2. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
3. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
4. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
5. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women
6. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
7. Postmenopausal breast cancer survivors at increased risk for bone fractures
8. Nursing mothers having surgery -- How long a wait to breastfeed safely?
9. Researchers close in on breast cancer vaccine
10. Simple question from your doctor can help identify your risk for breast cancer
11. Non-invasive and invasive breast cancers share the same genetic mutations

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... 2017 (PRWEB) , ... July ... ... global provider of enterprise-grade IT operations analytics and application performance monitoring (APM) ... of world’s largest healthcare services providers. , According to Peter Ohrenberger, sales ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... For individuals ... utmost importance. The adjustable beds used in such facilities are specially designed to accommodate ... adequate arm support. , An inventor from Rochester, Ind., has invented the patent-pending ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a ... for everyone affected by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon ... off on July 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, Inc. , ... systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round ... submissions and fund final engineering and initial production of the Company’s first product, ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... FDAnews Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... inspections and boosting quality. , It’s known as the “CY2016 Annual FDA Medical ...
Breaking Medicine News(10 mins):
(Date:7/19/2017)... 2017  Mako Medical Laboratories partnered with Secretary Strickland, ... Assistance Fund (MFA) to bring 140 soldiers back home ... their families one last time before being deployed. Mako ... and logistics needed for these soldiers. "Mako Medical Laboratories ... families. We just wish we could bring them all ...
(Date:7/13/2017)... , July 13, 2017  Centurion Medical Products, a leader in ... DisImpactor ® fecal impaction removal device for hospice patient care. ... Centurion Medical ... Patient pain management and emotional comfort ... can help alleviate patient pain while preventing unneeded emergency department admission ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known as ... can quantify biological aging in a precise manner using the myDNAge ™ ... Horvath , a professor of human genetics and biostatistics at the ... of Public Health , Zymo Research,s proprietary DNAge ™ technology is ... ...
Breaking Medicine Technology:
Cached News: